Clinical trial · no report yet · Phase 3

RTOG 0924 trial: what clinicians have said so far

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

NCT01368588 ↗
Active, not recruiting
Radiation Therapy Oncology Group
Deep size, estimated: 301+ verified statements

We haven't built an HCP commentary report on RTOG 0924 (unfavorable intermediate or favorable high risk prostate cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.

Indexed commentary on RTOG 0924 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

Indexed so far
28 posts on X
2 podcast episodes
1 YouTube video
1 video on X

Indexed todayTypical once built

The trial

ClinicalTrials.gov

Official title: Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Phase: Phase 3
Status: Active, not recruiting
Conditions: Prostate Cancer
Interventions: three-dimensional conformal radiotherapy; intensity modulated radiotherapy; Brachytherapy; Anti-androgen; luteinizing hormone-releasing hormone (LHRH) agonist or antagonist
Arms: Prostate/Seminal Vesicle Radiotherapy + ADT + Prostate Boost (Arm 1) · Active comparator
Whole Pelvic Radiotherapy + ADT + Prostate Boost (Arm 2) · Experimental
Enrollment: 2,590
Primary outcomes: Percentage of Participants Alive (Overall Survival)
Sponsor: Radiation Therapy Oncology Group with National Cancer Institute (NCI), NRG Oncology
Start: Jul 2011
Primary completion: Apr 17, 2025
Results posted: Yes
Registry record: NCT01368588 · updated May 8, 2026

Get this report

Deep

Report, built on orderBuilt within 24 hours of confirming your order: $1,950

Order this report

Quoted on an estimate of the verified statements in the commentary we've indexed so far. Final coverage is set when we build it.You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded.We build it within 24 hours of confirming your order. If we can't build it to our standard, you aren't charged.

Request a free preview

Ask us to build this report. Once it's built, its free preview (summary, finding titles and coverage) is published on this page and we email you the link. The full report is sold separately. Use your work email; we'll send a link to confirm it.

For agents: .json · .md

Indexed commentary on RTOG 0924 so far

Reports on the same drug or indication

The trial